Gene · 2042
Papers1,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery. | Theranostics | 2024 | 38773973 | PubTator, text mining | PubMed |
| Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain Barrier. | Mol Neurobiol | 2024 | 38558360 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor-2 Signals Clear-Cell Renal Carcinoma Proliferation via Phosphorylated 4E Binding Protein-1 and Mitochondrial Gene Translation. | Am J Pathol | 2024 | 38537932 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing unveils tumor heterogeneity and immune microenvironment between subungual and plantar melanoma. | Sci Rep | 2024 | 38528036 | PubTator, text mining | PubMed |
| Genetic mutation profiling reveals biomarkers for targeted therapy efficacy and prognosis in non-small cell lung cancer. | Heliyon | 2024 | 38496877 | PubTator, text mining | PubMed |
| Genetic architecture of the structural connectome. | Nat Commun | 2024 | 38438384 | PubTator, text mining | PubMed |
| Identification of the shared genes in type 2 diabetes mellitus and osteoarthritis and the role of quercetin. | J Cell Mol Med | 2024 | 38332532 | PubTator, text mining | PubMed |
| Genetic alterations predict poor efficacy, outcomes and resistance to second-line osimertinib treatment in non-small cell lung cancer. | Am J Cancer Res | 2024 | 38323283 | PubTator, text mining | PubMed |
| Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer. | RSC Adv | 2024 | 38292259 | PubTator, text mining | PubMed |
| Screening of Biomarkers Associated with Osteoarthritis Aging Genes and Immune Correlation Studies. | Int J Gen Med | 2024 | 38268862 | PubTator, text mining | PubMed |
| Chloride Intracellular Channel Protein 1 (CLIC1) Is a Critical Host Cellular Factor for Influenza A Virus Replication. | Viruses | 2024 | 38257829 | PubTator, text mining | PubMed |
| Translation into Clinical Practice of the G1-G7 Molecular Subgroup Classification of Glioblastoma: Comprehensive Demographic and Molecular Pathway Profiling. | Cancers (Basel) | 2024 | 38254850 | PubTator, text mining | PubMed |
| Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach. | Biomolecules | 2024 | 38254687 | PubTator, text mining | PubMed |
| Contrasting Effects of Cancer-Associated Mutations in EphA3 and EphB2 Kinases. | Biochemistry | 2024 | 38252844 | PubTator, text mining | PubMed |
| The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme. | Cells | 2024 | 38247816 | PubTator, text mining | PubMed |
| Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations. | Respir Res | 2024 | 38238740 | PubTator, text mining | PubMed |
| Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer. | Cell Commun Signal | 2024 | 38233864 | PubTator, text mining | PubMed |
| Single-cell analysis of the cellular landscape of vulvar melanoma provides new insight for immunotherapy administration. | BMC Cancer | 2024 | 38233802 | PubTator, text mining | PubMed |
| Feasibility and acceptability of phone-delivered psychological therapy for refugee children and adolescents in a humanitarian setting. | Confl Health | 2024 | 38218936 | PubTator, text mining | PubMed |
| Whole‑exome sequencing reveals Lewis lung carcinoma is a hypermutated Kras/Nras-mutant cancer with extensive regional mutation clusters in its genome. | Sci Rep | 2024 | 38167599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2042/papers?page=4